88S10223 TBO-D
By: Parker S.R. No. 14
R E S O L U T I O N
WHEREAS, Ehlers-Danlos Syndromes and Hypermobility Spectrum
Disorders Awareness Month took place in May 2023; and
WHEREAS, Ehlers-Danlos syndromes (EDS) include 13 heritable
connective tissue disorders that together affect an estimated 1 in
5,000 people; each disorder has its own set of symptoms, but all
types of EDS are characterized by joint hypermobility, skin
hyperextensibility, and tissue fragility; and
WHEREAS, Hypermobility spectrum disorders (HSD) are
connective tissue disorders that cause joint hypermobility,
instability, injury, and pain; in addition, other symptoms such as
fatigue, headaches, gastrointestinal problems, and autonomic
dysfunction are often a result of HSD; and
WHEREAS, There is currently no available cure for any type of
EDS or HSD, and treatments typically focus on addressing symptoms;
because the conditions can affect many different areas of the body,
patients often require multiple providers in different specialties
to manage their care; and
WHEREAS, Numerous patients impacted by EDS and HSD have
limited access to professionals who are knowledgeable about these
health issues; increased awareness about each condition is
necessary to help diagnose patients, improve symptom management,
and promote research initiatives; and
WHEREAS, More work remains to be done to ensure that all EDS
and HSD patients have access to quality health care, and the
observance of Ehlers-Danlos Syndromes and Hypermobility Spectrum
Disorders Awareness Month unites people across Texas and around the
world in their commitment to that endeavor; now, therefore, be it
RESOLVED, That the Senate of the 88th Texas Legislature, 1st
Called Session, hereby recognize May 2023 as Ehlers-Danlos
Syndromes and Hypermobility Spectrum Disorders Awareness Month.